The goal of the ADVANCE project is to help health professionals, regulatory agencies, public health institutions, vaccine manufacturers and the general public make more informed decisions on benefits and risks of marketed vaccines.



ADVANCE at the 2018 Big Data for Pharmacovigilance conference

The Big Data for Pharmacovigilance conference took place in London on 20-21st... READ MORE


ADVANCE at the 2018 Mackenzie Lecture & Conference

The Mackenzie Lecture is an annual event held in honour of Sir James Mackenzie,... READ MORE


ADVANCE in Horizon Magazine News

Horizon - The EU research & Innovation Magazine - brings you the latest... READ MORE


ADVANCE consortium has developed the ADVANCE Toolbox which can be used by the scientific community to streamline the monitoring of the health benefits and risks of vaccines in the post licensure phase. It comprises different online open source applications that allow to transform outcome definitions into diagnosis codes, to analyse and select vaccine codes in a given vaccine coding system, assess potential impact of possible disease- and exposure misclassification, derive prevalence estimates and validity indices and visualise near real-time monitoring of the post-marketing benefits and risks of vaccines. Moreover, researchers can use ADVANCE web catalogue to conduct an assessment of the ability of databases to contribute to future vaccine benefit-risk studies.